Members of the International Council of Biotechnology Associations (ICBA) work to promote public understanding of local and global biotechnology industries. Below are reports and other resources published by ICBA members that highlight key industry updates across the globe.

  • Value of Healthcare Biotech From Patent to Patient: The Importance of IP Rewards and Incentives

    To better understand the importance of IP rewards and incentives, EuropaBio conducted a survey among a cross section of key stakeholders, such as small and medium sized enterprises (SMEs) and venture capitalists involved in the healthcare biotechnology community. This report summarizes the findings of the EuropaBio survey and provides supplementary information on the value of IP rewards and incentives and for the healthcare biotechnology industry.

    View Publication
  • The Science of Amazing Canada’s Biotech Ecosystem

    BIOTECanada’s report on the opportunities and challenges facing Canada’s biotechnology industry.

    View Publication
  • The Long Path From Paper To Practice

    This paper highlights the status and perspectives of the bioeconomy in Germany.

    View Publication
  • The Italian Biotech Industry: Economic Update 2018

    The aim of this report is to present an update of the key facts and figures of the Italian biotech industry.

    The report can be found here.

    View Publication
  • The Green G-Nome’s Guide to GM Crops & Policies in the EU

    The Green G-Nome is ready to guide you to new heights of knowledge about GM crops. This new guide is a must read for anyone wanting to understand the role and untapped potential of GM crops in Europe.

    http://www.europabio.org/agricultural-biotech/publications/green-g-nomes-guide-gm-crops-policies-eu

    View Publication
  • TEConomy/BIO: The Value of Bioscience Innovation in Growing Jobs and Improving Quality of Life 2016

    This biennial report on State Biosciences Development takes stock of the value of bioscience innovation by considering the economic value that is found across the fast paced and ever changing world of bioscience industries.

    View Publication
  • Taiwan BIO Introduction

    This one-pager gives an overview of Taiwan Bio Industry Association’s activities.

    View Publication
  • Spain’s White Biotechnology Pipeline

    This pipeline contains the latest products developments by members of ASEBIO in the biotechnology industrial sector: bioprocesses, bioproducts, technologies and biofuels.

     

    View Publication
  • Spain’s Red Biotechnology Pipeline

    This pipeline contains the latest drug developments by members of ASEBIO: Spanish companies and multinational subsidiaries which have carried out some phases of the process in Spain.

     

    View Publication
  • Spain’s Green Biotechnology Pipeline

    This pipeline includes products developments by ASEBIO members in the biotechnology Agrofood sector: ingredients, additives and probiotics, food safety substance detection, bioproducts, bioprocesses and other technologies, feed, veterinary drugs and biofuels.

    View Publication
  • Spain Biotech Sector 2016 – Quick start guide

    Background information on the Spanish biotechnology sector.

    View Publication
  • Spain Asebio Report 2016

    Background information on the Spanish biotechnology sector.

    View Publication
  • Research at Japanese Universities

    Researchers at Japanese universities have made significant strides in biotechnology innovation. This handout lists some of those notable contributions.

    View Publication
  • Panorama France Healthtech 2019

    France Biotech’s analysis of the 2019 French biotech sector.

    View Publication
  • Leading Innovation – The UK’s ATMP Landscape

    The Alliance for Regenerative Medicine (ARM) and the BioIndustry Association (BIA) have published a report setting out the scope of the UK’s robust and growing Advanced Therapy Medicinal Products (ATMPs) sector, which includes the development of potentially transformative cell and gene therapies.

    View Publication
  • Jobs and Growth Generated by Industrial Biotechnology in Europe

    EuropaBio’s report looks at the different economic effects associated with the activities of the industrial biotechnology (IB) sector in Europe. The full report can found be here.

    View Publication
  • Japan’s Bioeconomy Vision Outline

    JBA’s position paper on the bioindustry’s contributions and potential solutions towards solving global health challenges.

    View Publication
  • Italy – 2016 Report

    This report presents the key facts and data of the Italian biotech industry and provides a brief analysis of the current context within which Italian companies are operating.

    View Publication
  • Intellectual Property Policy Paper

    The global life sciences industry, fueled by the effective intellectual property (IP) systems, has generated hundreds of medicines, medical diagnostic tests, climate and pest-resistant crops, and environmentally beneficial products, such as renewable fuels and bio-based plastics. The vast majority of biotechnology companies are small and medium sized enterprises that currently do not have products on the market. As such, these companies rely heavily on the strength and scope of their IP to attract investments needed to fund the costly research and development of delivering safe and effective technologies to the people and planet.

    View Publication
  • ICBA Statement on COVID-19

    In these unprecedented times, global biotechnology companies, both large and small, are coming together to work on vaccines, therapeutics and diagnostics to eradicate COVID-19. Global collaborations and the decades-long investments we have made in new technology, research and treatments have led to a multitude of efforts to develop vaccines and treatments for COVID-19. This statement relays the global industry’s commitments to finding treatments and vaccines for COVID-19 as well as delineates the policies needed to support R&D efforts.

    View Publication
  • Global and Growing: UK Biotech Financing in 2019

    New figures by the UK BioIndustry Association (BIA) and Informa Pharma Intelligence reveal that the UK biotech sector raised £1.3 billion in 2019. The total is the third highest year recorded by the trade association and since 2012 investment has increased by over 400%.

    View Publication
  • Genome Editing Policy Paper

    Innovation in the biotechnology sector has led to a critical scientific breakthrough – genome editing. Genome editing is an umbrella term for a range of tools that enable precise changes to the genome, the organism’s code of life. Applied worldwide by researchers in academia, governmental research institutions and industry, genome editing represents a promising next step in research towards beneficial uses in medicine, agriculture and the bio-economy aimed at addressing some of society’s grand challenges.

    This document provides background information on the science of this emerging technology.

    View Publication
  • French HealthTech

    A report on France and its potential for becoming a global leader in biotech from France Biotech and The Boston Consulting Group.

    View Publication
  • EuropaBio Mid-Term Alert to the EU Commission, Parliament and Council

    How the EU should put innovation friendly policies back at the heart of their agenda.

    View Publication
  • Essential Costa Rica

    An overview of the strengths of the Costa Rican biotechnology sector and CRBiomed’s role in its continued growth.

    View Publication
  • Engineering Biology Explained

    Engineering Biology Explained: A guide to engineering biology and UK excellence in the field.

    View Publication
  • Costa Rica Life Sciences Sector Guide

    A handout describing the strengths of the Costa Rican biotechnology sector.

    View Publication
  • Confident Capital: Backing UK Biotech

    This Report released by the UK BioIndustry Association (BIA) and Informa Pharma Intelligence reveals that the UK biotech sector raised a record £2.2 billion from investors in 2018. The total is the best ever recorded by the trade association and almost double that raised in 2017.

    View Publication
  • Cell and Gene Therapy Explained

    Cell and Gene Therapy Explained: A guide to cell and gene therapy and UK excellence in the field.

    View Publication
  • Building the Bioeconomy 2018 Report

    Developed by the Pugatch Consilium, this report highlights strategies, policies and best practices that have been successful in creating an enabling environment for biotechnology innovation. The fifth edition of the Building the Bioeconomy report shows the correlation between economies with pro-innovation policy frameworks and those achieving strong biotechnology outputs. By examining 28 different indicators, the report provides a full and detailed analysis of the biotechnology environment for 33 countries from all major regions of the world.

    View Publication
  • Biotechnology: Driving Solutions to the United Nations Sustainable Development Goals

    The biotechnology sector is helping to contribute solutions to achieve the United Nations Sustainable Development Goals (UN SDGs). This resource highlights examples of new technologies and partnerships undertaken by the global biotechnology sector in an attempt to help achieve the UN SDGs.

    View Publication
  • Biotech Primer Training

    Biotech Primer Inc., in partnership with BIO, offers on-demand online training classes that can be taken anywhere, anytime and at your own pace. Biotech Primer delivers current, relevant training to help professionals understand the science, business, and regulatory processes essential to the Biotechnology, Pharmaceutical, Molecular Diagnostics and Medical Device industries. Now offering discounts for ICBA member organizations, learn more here: https://www.bio.org/bio-online-learning-discount-offer     

    View Publication
  • BioInItaly Report 2020

    The BioInItaly Report 2020, drafted in collaboration between Assobiotec (Italian Association for the Development of Biotechnology, part of Federchimica) and ENEA (National Agency for New Technologies, Energy and Sustainable Economic Development), offers an update on the current state of the Italian biotech industry.

    The work presents analysis and estimates based on information provided by the firms operating in the sector at the end of 2019, their 2018 financial statements, public data and data from the National Statistical System.

    View Publication
  • BIO Deutschland- German Biotech FactSheet

    BIO Deutschland collects annual data on small and medium-sized businesses that, according to OECD criteria, operate in the biotechnology sector. These key performance indicators were published in collaboration with EY.

    View Publication
  • BIO Deutschland Positions

    This document outlines key policy positions in the following topics: finance and taxation; licences and technical contracts; regulatory matters; innovation and entrepreneurship; HR; German-US cooperation; health policy; competition and regulatory policy; technology transfer; and PR.

    View Publication
  • BBC StoryWorks To Produce Biotech Webseries

    The International Council of Biotechnology Associations (ICBA) is pleased to announce a series of mini-documentary style films to be produced by BBC StoryWorks, the commercial creative arm of BBC Global News.

    The series will examine the role of biotechnology in solving some the world’s greatest environmental and health challenges. Carbon emissions, disease, more sustainable and efficient farming and manufacturing practices; biotechnology is playing a central role in solving complex problems, improving the health of humankind and the planet.

     

    The series will showcase projects from across the globe, highlighting the innovative ways in which organisations are leveraging advances in biotechnology to manage disease and treatment. It will examine biotech’s role in food production; its focus on sustainability, reducing emissions and chemical use.

    The aim is to tell the stories of the passionate people driving these products and technologies forward and those who are benefiting from the innovation. We want to show the commitment and dedication of the individuals and businesses at the heart of the industry.

    View Publication
  • Antimicrobial Resistance Explained: A Guide to Antimicrobial Resistance and How UK Excellence is Helping Tackle this Global Ghallenge

    Antibiotics are a triumph of modern medicine. Alexander Fleming’s famously serendipitous discovery of penicillin during the 1920s led to one of the most effective treatments for bacterial infections, still in use today. But the success of penicillin and many other antibiotics developed since has created an entirely new, arguably even bigger healthcare challenge, that of antimicrobial resistance (AMR).

    Bacteria have learned to out-smart antimicrobial molecules and have developed resistance. Bacteria reproduce and evolve far faster than humans and most animals, and they can share helpful DNA easily among each other, not just with their offspring.

    This document explains more on AMR and what BIA member companies are doing to tackle it.

    View Publication
  • Achieving the Potential of Genome Editing

    EuropaBio’s paper brings the latest views from the developers and users of genome editing tools and applications. This paper seeks to support the ongoing discussion about how to increase the public understanding of these tools and the solutions that come with them, as well as how to best develop any needed regulatory policies to enable their potential.

    View Publication
  • A Vision for the UK Life Sciences Sector in 2025

    This report provides a roadmap for the growth of the UK biotechnology industry.

    View Publication
  • A Guide to Genomics

    Genomics Explained: A guide to genomics and UK excellence in the field.

    View Publication